The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Human Natural Antibodies to Mammalian Carbohydrate Antigens as Unsung Heroes Protecting against Past, Present, and Future Viral Infections
Abstract
Human natural antibodies to mammalian carbohydrate antigens (MCA) bind to carbohydrate-antigens synthesized in other mammalian species and protect against zoonotic virus infections. Three such anti-MCA antibodies are: (1) anti-Gal, also produced in Old-World monkeys and apes, binds to α-gal epitopes synthesized in non-primate mammals, lemurs, and New-World monkeys; (2) anti-Neu5Gc binds to Neu5Gc (N-glycolyl-neuraminic acid) synthesized in apes, Old-World monkeys, and many non-primate mammals; and (3) anti-Forssman binds to Forssman-antigen synthesized in various mammals. Anti-viral protection by anti-MCA antibodies is feasible because carbohydrate chains of virus envelopes are synthesized by host glycosylation machinery and thus are similar to those of their mammalian hosts. Analysis of MCA glycosyltransferase genes suggests that anti-Gal appeared in ancestral Old-World primates following catastrophic selection processes in which parental populations synthesizing α-gal epitopes were eliminated in enveloped virus epidemics. However, few mutated offspring in which the α1,3galactosyltransferase gene was accidentally inactivated produced natural anti-Gal that destroyed viruses presenting α-gal epitopes, thereby preventing extinction of mutated offspring. Similarly, few mutated hominin offspring that ceased to synthesize Neu5Gc produced anti-Neu5Gc, which destroyed viruses presenting Neu5Gc synthesized in parental hominin populations. A present-day example for few humans having mutations that prevent synthesis of a common carbohydrate antigen (produced in >99.99% of humans) is blood-group Bombay individuals with mutations inactivating H-transferase; thus, they cannot synthesize blood-group O (H-antigen) but produce anti-H antibody. Anti-MCA antibodies prevented past extinctions mediated by enveloped virus epidemics, presently protect against zoonotic-viruses, and may protect in future epidemics. Travelers to regions with endemic zoonotic viruses may benefit from vaccinations elevating protective anti-MCA antibody titers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These antibodies may protect humans from pathogens that express α-Gal epitopes, including viruses, bacteria, and protozoa”
From ABO blood group antigens and differential glycan expression: Perspective on the evolution of common human enzyme deficiencies (2023) · cites this paper as Galili, 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intestinal microbiota in human health and disease: the impact of probiotics
Gerritsen, J., Smidt, H., Rijkers, G. T., & de Vos, W. M. (2011) · Genes & Nutrition · doi:10.1007/s12263-011-0229-7 · Cited by 724
Potential impact of the non‐human sialic acid N‐glycolylneuraminic acid on transplant rejection risk
Padler‐Karavani, V., & Varki, A. (2011) · Xenotransplantation · doi:10.1111/j.1399-3089.2011.00622.x · Cited by 162 · cited 1×
“The natural anti-Neu5Gc antibody, similar to anti-Gal, is produce in humans [44–46], and can mediate rejection of xenografts [45,47,49].”
BackgroundSteiper, M. E., Young, N. M., & Sukarna, T. Y. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407270101 · Cited by 149
Absence of Neu5Gc and Presence of Anti-Neu5Gc Antibodies in Humans—An Evolutionary Perspective
Altman, M. O., & Gagneux, P. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00789 · Cited by 112
Research works printed but not linked: 141
- Ochsenbein, 1999, Control of early viral and bacterial distribution and disease by natural antibodies, Science, 286, 2156, 10.1126/science.286.5447.2156 · DOI · Paper page
- Bovin, 2013, Natural antibodies to glycans, Biochemistry [Moscow], 78, 786, 10.1134/S0006297913070109 · DOI
- Blixt, 2004, Printed covalent glycan array for ligand profiling of diverse glycan binding proteins, Proc. Natl. Acad. Sci. USA, 101, 17033, 10.1073/pnas.0407902101 · DOI · Paper page
- Stowell, 2014, Microbial glycan microarrays define key features of host-microbial interactions, Nat. Chem. Biol., 10, 470, 10.1038/nchembio.1525 · DOI · Paper page
- Wiener, 1951, Origin of naturally occurring hemagglutinins and hemolysins; a review, J. Immunol., 66, 287, 10.4049/jimmunol.66.2.287 · doi:10.4049/jimmunol.66.2.287
- Springer, 1971, Blood-group and Forssman antigenic determinants shared between microbes and mammalian cells, Prog. Allergy, 15, 9
- Hooperm, 2010, Immune adaptation that maintain homeostasis with intestinal microbiota, Nat. Rev. Immunol., 10, 159, 10.1038/nri2710 · DOI · Paper page
- Watkins, 1980, Biochemistry and Genetics of the ABO, Lewis, and P blood group systems, Adv. Hum. Genet., 10, 379
- Galili, 1984, A unique natural human IgG antibody with anti-α-galactosyl specificity, J. Exp. Med., 160, 1519, 10.1084/jem.160.5.1519 · DOI · Paper page
- Hamadeh, 1995, Human secretions contain IgA, IgG and IgM anti-Gal [anti-α-galactosyl] antibodies, Clin. Diagn. Lab. Immunol., 2, 125, 10.1128/cdli.2.2.125-131.1995 · DOI
- McMorrow, 1997, Heterogeneity of human anti-pig natural antibodies cross-reactive with the Gal[α1,3]Galactose epitope, Transplantation, 64, 501, 10.1097/00007890-199708150-00021 · DOI
- Parker, 1999, Naturally occurring anti-α-galactosyl antibodies: Relationship to xenoreactive anti- α-galactosyl antibodies, Glycobiology, 9, 865, 10.1093/glycob/9.9.865 · DOI
- Galili, 1993, One percent of circulating B lymphocytes are capable of producing the natural anti-Gal antibody, Blood, 82, 2485, 10.1182/blood.V82.8.2485.2485 · DOI · Paper page
- Wang, 1995, Variations in activity of the human natural anti-Gal antibody in young and elderly populations, J. Gerontol. Med. Sci., 50A, M227, 10.1093/gerona/50A.4.M227 · doi:10.1093/gerona/50a.4.m227
- Galili, 1988, Interaction between human natural anti-α-galactosyl immunoglobulin G and bacteria of the human flora, Infect. Immun., 56, 1730, 10.1128/iai.56.7.1730-1737.1988 · DOI · Paper page
- Posekany, 2002, Induction of cytolytic anti-Gal antibodies in α-1,3-galactosyltransferase gene knockout mice by oral inoculation with Escherichia coli O86:B7 bacteria, Infect. Immun., 70, 6215, 10.1128/IAI.70.11.6215-6222.2002 · DOI
- Blanco, 2001, Removal of bowel aerobic gram-negative bacteria is more effective than immunosuppression with cyclophosphamide and steroids to decrease natural α-galactosyl IgG antibodies, Xenotransplantation, 8, 15, 10.1034/j.1399-3089.2001.00082.x · DOI
- Galili, 1985, Human natural anti-α-galactosyl IgG. II. The specific recognition of α[1,3]-linked galactose residues, J. Exp. Med., 162, 573, 10.1084/jem.162.2.573 · DOI · Paper page
- Towbin, 1987, Circulating antibodies to mouse laminin in Chagas disease, American cutaneous leishmaniasis, and normal individuals recognize terminal galactosyl [α1-3]-galactose epitopes, J. Exp. Med., 166, 419, 10.1084/jem.166.2.419 · DOI · Paper page
- Teneberg, 1996, Molecular mimicry in the recognition of glycosphingolipids by Galα3Galß4GlcNAcß-binding Clostridium difficile toxin A, human natural anti-α-galactosyl IgG and the monoclonal antibody Gal-13: Characterization of a binding-active human glycosphingolipid, non-identical with the animal receptor, Glycobiology, 6, 599, 10.1093/glycob/6.6.599 · DOI
- Wang, 1995, Human anti-Gal heavy chain genes: Preferential use of VH3 and the presence of somatic mutations, J. Immunol., 155, 1276, 10.4049/jimmunol.155.3.1276 · DOI
- Galili, 1987, The human natural anti-Gal IgG. III. The subtlety of immune tolerance in man as demonstrated by crossreactivity between natural anti-Gal and anti-B antibodies, J. Exp. Med., 165, 693, 10.1084/jem.165.3.693 · DOI · Paper page
- Galili, 1987, Evolutionary relationship between the anti-Gal antibody and the Galα1-3Gal epitope in primates, Proc. Natl. Acad. Sci. USA, 84, 1369, 10.1073/pnas.84.5.1369 · DOI · Paper page
- Galili, 1988, Man, apes, and Old-World monkeys differ from other mammals in the expression of α-galactosyl epitopes on nucleated cells, J. Biol. Chem., 263, 17755, 10.1016/S0021-9258(19)77900-9 · DOI · Paper page
- Basu, 1973, Enzymatic synthesis of blood group related pentaglycosyl ceramide by an α-galactosyltransferase, J. Biol. Chem., 248, 1700, 10.1016/S0021-9258(19)44247-6 · DOI
- Larsen, 1990, Frameshift and nonsense mutations in a human genomic sequence homologous to a murine UDP-Gal:β-D-Gal[1,4]-D-GlcNAc α[1,3]-galactosyltransferase cDNA, J. Biol. Chem., 265, 7055, 10.1016/S0021-9258(19)39258-0 · DOI · Paper page
- Galili, 1991, Gene sequences suggest inactivation of α1-3 galactosyltransferase in catarrhines after the divergence of apes from monkeys, Proc. Natl. Acad. Sci. USA, 88, 7401, 10.1073/pnas.88.16.7401 · DOI · Paper page
- Koike, 2002, Molecular basis of evolutionary loss of the α1,3-galactosyltransferase gene in higher primates, J. Biol. Chem., 277, 10114, 10.1074/jbc.M110527200 · DOI
- Lanteri, 2002, A complete α1,3-galactosyltransferase gene is present in the human genome and partially transcribed, Glycobiology, 12, 785, 10.1093/glycob/cwf087 · DOI · Paper page
- Teranishi, 2002, Anti-Galα 1-3Gal IgM and IgG antibody levels in sera of humans and old world non-human primates, Xenotransplantation, 9, 148, 10.1034/j.1399-3089.2002.1o058.x · DOI
- Good, 1992, Identification of carbohydrate structures which bind human anti-porcine antibodies: Implication for discordant xenografting in man, Transplant. Proc., 24, 559
- Galili, 1993, Interaction of the natural anti-Gal antibody with α-galactosyl epitopes: A major obstacle for xenotransplantation in humans, Immunol. Today, 14, 480, 10.1016/0167-5699(93)90261-I · DOI · Paper page
- Cooper, 1993, Identification of α-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: Relevance to discordant xenografting in man, Transpl. Immunol., 1, 198, 10.1016/0966-3274(93)90047-C · DOI · Paper page
- Sandrin, 1993, Anti-pig IgM antibodies in human serum react predominantly with Gal (αl-3)Gal epitopes, Proc. Natl. Acad. Sci. USA, 90, 11391, 10.1073/pnas.90.23.11391 · DOI · Paper page
- Collins, 1995, Cardiac xenografts between primate species provide evidence for the importance of the α-galactosyl. determinant in hyperacute rejection, J. Immunol., 154, 5500, 10.4049/jimmunol.154.10.5500 · DOI · Paper page
- Xu, 1998, Removal of anti-porcine natural antibodies from human and nonhuman primate plasma in vitro and in-vivo by a Galα1-3Galβ1-4βGlc-X immunoaffinity column, Transplantation, 65, 172, 10.1097/00007890-199801270-00005 · DOI · Paper page
- Shaw, 1988, The biosynthesis of N-glycoloylneuraminic acid occurs by hydroxylation of the CMP-glycoside of N-acetylneuraminic acid, Biol. Chem. Hoppe. Seyler, 369, 477, 10.1515/bchm3.1988.369.1.477 · DOI
- Muchmore, 1998, A structural difference between the cell surfaces of humans and the great apes, Am. J. Phys. Anthropol., 107, 187, 10.1002/(SICI)1096-8644(199810)107:2<187::AID-AJPA5>3.0.CO;2-S · doi:10.1002/(sici)1096-8644(199810)107:2<187::aid-ajpa5>3.0.co;2-s
- Gagneux, 1999, Evolutionary considerations in relating oligosaccharide diversity to biological function, Glycobiology, 9, 747, 10.1093/glycob/9.8.747 · DOI · Paper page
- Varki, 2010, Colloquium paper: Uniquely human evolution of sialic acid genetics and biology, Proc. Natl. Acad. Sci. USA, 107, 8939, 10.1073/pnas.0914634107 · DOI · Paper page
- Chou, 1998, A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence, Proc. Natl. Acad. Sci. USA, 95, 11751, 10.1073/pnas.95.20.11751 · DOI · Paper page
- Irie, 1998, The molecular basis for the absence of N-glycolylneuraminic acid in humans, J. Biol. Chem., 273, 15866, 10.1074/jbc.273.25.15866 · DOI · Paper page
- Merrick, 1978, Characterization of the Hanganutziu-Deicher [serum-sickness] antigen as gangliosides containing N-glycolylneuraminic acid, Int. Arch. Allergy Appl. Immunol., 57, 477, 10.1159/000232140 · DOI
- Zhu, 2002, Anti-N-glycolylneuraminic acid antibodies identified in healthy human serum, Xenotransplantation, 9, 376, 10.1034/j.1399-3089.2002.02138.x · DOI · Paper page
- Yu, 2008, Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: Potential implications for disease, Glycobiology, 18, 818, 10.1093/glycob/cwn072 · DOI · Paper page
- Tahara, 2010, Immunological property of antibodies against N-glycolylneuraminic acid epitopes in cytidine monophospho-N-acetylneuraminic acid hydroxylase-deficient mice, J. Immunol., 184, 3269, 10.4049/jimmunol.0902857 · DOI
- Nguyen, 2005, Effects of natural human antibodies against a nonhuman sialic acid that metabolically incorporates into activated and malignant immune cells, J. Immunol., 175, 228, 10.4049/jimmunol.175.1.228 · DOI
- Young, 1979, Characterization of anti-Forssman [anti-Fs] antibodies in human sera: Their specificity and possible changes in patients with cancer, J. Immunol., 123, 92, 10.4049/jimmunol.123.1.92 · DOI
- Takahashi, 1981, Anti-Forssman antibody in human sera: Properties and decreased level in cancer patients, Jpn. J. Exp. Med., 51, 149
- Siddiqui, 1971, A revised structure for the Forssman glycolipid hapten, J. Biol. Chem., 246, 5766, 10.1016/S0021-9258(18)61871-X · doi:10.1016/s0021-9258(18)61871-x
- Das, 1986, Biosynthesis in vitro of a globoside containing a 2-acetamido-2-deoxy-beta-D-galactopyranosyl group [1-.3]- linked and Forssman glycolipid by two N-acetylgalactosaminyltransferases from chemically transformed guinea pig cells, Carbohydr. Res., 149, 119, 10.1016/S0008-6215(00)90373-2 · doi:10.1016/s0008-6215(00)90373-2
- Haslam, 1996, Expression cloning of Forssman glycolipid synthetase: A novel member of the histo-blood group ABO gene family, Proc. Natl. Acad. Sci. USA, 93, 10697, 10.1073/pnas.93.20.10697 · DOI
- Narasimhan, 1978, Comparative study of the glycosphingolipids of chicken bursa of Fabricius and of chicken, rat and human thymus, Biochem. J., 173, 475, 10.1042/bj1730475 · doi:10.1042/bj1730475
- Breimer, 1981, Blood group type glycosphingolipids from the small intestine of different animals analyzed by mass spectrometry and thin-layer chromatography. A note on species diversity, J. Biochem., 90, 589, 10.1093/oxfordjournals.jbchem.a133513 · DOI
- Yamamoto, 2012, Molecular genetic basis of the human Forssman glycolipid antigen negativity, Sci. Rep., 2, 975, 10.1038/srep00975 · DOI
- Jesus, 2018, Prevalence of antibodies to a new histo-blood system: The FORS system, Blood Transfus., 16, 178
- Varki, A., Cummings, R.D., and Esko, J.D. (2019, March 15). Glycosyltransferases and Glycan-Processing Enzymes [Chapter 6], Essentials of Glycobiology [Internet], Available online: https://www.ncbi.nlm.nih.gov/books/NBK310274/.
- Repik, 1994, Differential host dependent expression of α-galactosyl epitopes on viral glycoproteins: A study of Eastern equine encephalitis virus as a model, J. Gen. Virol., 75, 1177, 10.1099/0022-1317-75-5-1177 · DOI
- Galili, 1996, Enhancement of antigen presentation of influenza virus hemagglutinin by the natural anti-Gal antibody, Vaccine, 14, 321, 10.1016/0264-410X(95)00189-8 · DOI
- Pipperger, 2019, Xenoantigen-dependent complement-mediated neutralization of LCMV glycoprotein pseudotyped VSV in human serum, J. Virol., 93, e00567-19, 10.1128/JVI.00567-19 · DOI
- Smith, 1990, Transfer and expression of a murine UDP-Gal:β-D-Gal-α1,3-galactosyltransferase gene in transfected Chinese hamster ovary cells. Competition reactions between the α1,3-galactosyltransferase and the endogenous α2,3-sialyltransferase, J. Biol. Chem., 265, 6225, 10.1016/S0021-9258(19)39314-7 · DOI
- Taatjes, 1987, Distribution of galactosyl- and sialyltransferase: Reorganization of trans Golgi apparatus elements in hepatocytes in intact liver and cell culture, Eur. J. Cell Biol., 44, 187
- Henion, 1997, Synthesis of α-gal epitopes on influenza virus vaccines, by recombinant α1,3galactosyltransferase, enables the formation of immune complexes with the natural anti-Gal antibody, Vaccine, 15, 1174, 10.1016/S0264-410X(96)00300-3 · DOI
- Rother, 1995, A novel mechanism of retrovirus inactivation in human serum mediated by anti-α-galactosyl natural antibody, J. Exp. Med., 182, 1345, 10.1084/jem.182.5.1345 · DOI · Paper page
- Takeuchi, 1996, Sensitization of cells and retroviruses to human serum by [α1-3] galactosyltransferase, Nature, 379, 85, 10.1038/379085a0 · DOI · Paper page
- Patience, 1997, Infection of human cells by an endogenous retrovirus of pigs, Nat. Med., 3, 282, 10.1038/nm0397-282 · DOI · Paper page
- Takeuchi, 1997, Sensitization of rhabdo-, lenti-, and spumaviruses to human serum by galactosyl(α1-3)galactosylation, J. Virol., 71, 6174, 10.1128/jvi.71.8.6174-6178.1997 · DOI
- Welsh, 1998, Evaluation of the Galα1-3Gal epitope as a host modification factor eliciting natural humoral immunity to enveloped viruses, J. Virol., 72, 4650, 10.1128/JVI.72.6.4650-4656.1998 · DOI
- Hayashi, 2004, The neutralization of pseudorabies virus by anti-α-galactocyl natural antibody in normal serum, Virus Res., 99, 1, 10.1016/j.virusres.2003.09.008 · DOI
- Preece, 2002, Expression of ABO or related antigenic carbohydrates on viral envelopes leads to neutralization in the presence of serum containing specific natural antibodies and complement, Blood, 99, 2477, 10.1182/blood.V99.7.2477 · DOI · Paper page
- Baple, 2007, Virus recognition by specific natural antibodies and complement results in MHC I cross-presentation, J. Immunol., 37, 1254
- Kim, 2007, Natural protection from zoonosis by α-gal epitopes on virus particles in xenotransmission, Xenotransplantation, 14, 104, 10.1111/j.1399-3089.2007.00377.x · DOI
- Cheng, 2005, ABO blood group and susceptibility to severe acute respiratory syndrome, JAMA, 293, 1450
- Guillon, 2008, Inhibition of the interaction between the SARS-CoV spike protein and its cellular receptor by anti-histo-blood group antibodies, Glycobiology, 18, 1085, 10.1093/glycob/cwn093 · DOI · Paper page
- Paradis, 1999, Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group, Science, 285, 1236, 10.1126/science.285.5431.1236 · DOI · Paper page
- Houston, 1977, Inactivated Venezuelan equine encephalomyelitis virus vaccine complexed with specific antibody: Enhanced primary immune response and altered pattern of antibody class elicited, J. Infect. Dis., 135, 600, 10.1093/infdis/135.4.600 · doi:10.1093/infdis/135.4.600
- Villinger, 2003, Evidence for antibody-mediated enhancement of simian immunodeficiency virus [SIV] Gag antigen processing and cross presentation in SIV-infected rhesus macaques, J. Virol., 77, 10, 10.1128/JVI.77.1.10-24.2003 · DOI
- Wen, 1999, Antigen-antibody complex as therapeutic vaccine for viral hepatitis B, Int. Rev. Immunol., 18, 251, 10.3109/08830189909043028 · doi:10.3109/08830189909043028
- Wigglesworth, 2009, Mechanism for increased immunogenicity of vaccines that form in-vivo immune complexes with the natural anti-Gal antibody, Vaccine, 27, 3072, 10.1016/j.vaccine.2009.03.019 · DOI
- Guay, 2007, Increased immunogenicity of influenza virus vaccine by anti-Gal mediated targeting to antigen presenting cells, J. Virol., 81, 9131, 10.1128/JVI.00647-07 · DOI
- Wang, 2006, Increased Immunogenicity of Human Immunodeficiency Virus gp120 Engineered to Express Galα1-3Galβ1-4GlcNAc-R Epitopes, J. Virol., 80, 6943, 10.1128/JVI.00310-06 · DOI
- Wang, 2010, Increased immunogenicity of HIV-1 p24 and gp120 following immunization with gp120/p24 fusion protein vaccine expressing α-gal epitopes, Vaccine, 28, 1758, 10.1016/j.vaccine.2009.12.015 · DOI
- Benatuil, 2005, The influence of natural antibody specificity on antigen immunogenicity, Eur. J. Immunol., 35, 2638, 10.1002/eji.200526146 · DOI
- Galili, 2007, Intratumoral injection of α-gal glycolipids induces xenograft-like destruction and conversion of lesions into endogenous vaccines, J. Immunol., 178, 4676, 10.4049/jimmunol.178.7.4676 · DOI
- Buonomano, 1999, Quantitation and characterization of anti-Galα1-3Gal antibodies in sera of 200 healthy persons, Xenotransplantation, 6, 173, 10.1034/j.1399-3089.1999.00023.x · DOI
- Maruyama, 1999, Interaction of baboon anti-α-galactosyl antibody with pig tissues, Am. J. Pathol., 155, 1635, 10.1016/S0002-9440(10)65479-X · DOI
- Galili, U. (2018). The Natural Anti-Gal Antibody as Foe Turned Friend in Medicine, Elsevier, Academic Press.
- Galili, 1995, Increased anti-Gal activity in diabetic patients transplanted with fetal porcine islet cell clusters, Transplantation, 59, 1549, 10.1097/00007890-199506150-00008 · DOI
- Almeida, 1991, Complement-mediated lysis of Trypanosoma cruzi trypomastigotes by human anti-α-galactosyl antibodies, J. Immunol., 146, 2394, 10.4049/jimmunol.146.7.2394 · DOI
- Almeida, 1994, Lytic anti-α-galactosyl antibodies from patients with chronic Chagas’ disease recognize novel O-linked oligosaccharides on mucin-like glycosyl-phosphatidylinositol-anchored glycoproteins of Trypanosoma cruzi, Biochem. J., 304, 793, 10.1042/bj3040793 · DOI · Paper page
- Ramasamy, 1987, Terminal galactose residues and the antigenicity of Plasmodium falciparum glycoproteins, J. Clin. Microbiol., 25, 2075
- Ravindran, 1988, Naturally-occurring anti-α-galactosyl antibodies in human Plasmodium falciparum infections: A possible role for autoantibodies in malaria, Immunol. Lett., 19, 137, 10.1016/0165-2478(88)90133-2 · DOI
- Ramasamy, 1997, Association of malaria with inactivation of α1,3-galactosyl transferase in catarrhines, Biochim. Biophys. Acta, 1360, 241, 10.1016/S0925-4439(97)00005-7 · doi:10.1016/s0925-4439(97)00005-7
- Yilmaz, 2014, Gut microbiota elicits a protective immune response against malaria transmission, Cell, 159, 1277, 10.1016/j.cell.2014.10.053 · DOI · Paper page
- Alberdi, 2017, Effect of blood type on anti-α-Gal immunity and the incidence of infectious diseases, Exp. Mol. Med., 10, e301
- Groth, 1994, Transplantation of fetal porcine pancreas to diabetic patients: Biochemical and histological evidence for graft survival, Lancet, 344, 1402, 10.1016/S0140-6736(94)90570-3 · DOI · Paper page
- Whalen, 2012, Cancer Immunotherapy by intratumoral injection of α-gal glycolipids, Anticancer Res., 32, 3861
- Konakci, 2005, α-gal on bioprostheses: Xenograft immune response in cardiac surgery, Eur. J. Clin. Investig., 35, 17, 10.1111/j.1365-2362.2005.01441.x · DOI · Paper page
- Böer, U., Buettner, F.F.R., Schridde, A., Klingenberg, M., Sarikouch, S., Haverich, A., and Wilhelmi, M. (2017). Antibody formation towards porcine tissue in patients implanted with crosslinked heart valves is directed to antigenic tissue proteins and αGal epitopes and is reduced in healthy vegetarian subjects. Xenotransplantation, 24. · DOI
- Stone, 2007, Replacement of human anterior cruciate ligament with pig ligament: A model for anti-non gal antibody response in long-term xenotransplantation, Transplantation, 83, 211, 10.1097/01.tp.0000250598.29377.13 · DOI
- Feldmann, 1994, Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein, Virology, 199, 469, 10.1006/viro.1994.1147 · doi:10.1006/viro.1994.1147
- Commins, 2013, Tick bites and red meat allergy, Curr. Opin. Allergy Clin. Immunol., 13, 354, 10.1097/ACI.0b013e3283624560 · DOI
- Wilson, 2019, Investigation into the α-Gal Syndrome: Characteristics of 261 Children and Adults Reporting Red Meat Allergy, J. Allergy. Clin. Immunol. Pract., 7, 2348, 10.1016/j.jaip.2019.03.031 · DOI · Paper page
- Schrago, 2013, Combining fossil and molecular data to date the diversification of New World primates, J. Evol. Biol., 26, 2438, 10.1111/jeb.12237 · DOI
- Larsen, 1989, Isolation of a cDNA encoding murine UDP galactose: ßD-galactosyl-1,4-N-acetyl-D-glucosaminide α1,3-galactosyltransferase: Expression cloning by gene transfer, Proc. Natl. Acad. Sci. USA, 86, 8227, 10.1073/pnas.86.21.8227 · DOI · Paper page
- Joziasse, 1989, Bovine α1-3galactosyltransferase: Isolation and characterization of a cDNA clone. Identification of homologous sequences in human genomic DNA, J. Biol. Chem., 264, 14290, 10.1016/S0021-9258(18)71676-1 · DOI · Paper page
- Henion, 1994, Defining the minimal size of catalytically active primate α1,3galactosyltransferase: Structure function studies on the recombinant truncated enzyme, Glycobiology, 4, 193, 10.1093/glycob/4.2.193 · DOI
- Miller, 2009, Systematics of early and middle Miocene Old World monkeys, J. Hum. Evol., 57, 195, 10.1016/j.jhevol.2009.06.006 · DOI
- Lewis, 1962, Catastrophic selection as a factor in speciation, Evolution, 16, 257, 10.2307/2406275 · DOI
- Lai, 2002, Production of α-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning, Science, 295, 1089, 10.1126/science.1068228 · DOI · Paper page
- Phelps, 2003, Production of α1,3-galactosyltransferase-deficient pigs, Science, 299, 411, 10.1126/science.1078942 · DOI · Paper page
- Dor, 2004, α1,3-Galactosyltransferase gene-knockout miniature swine produce natural cytotoxic anti-Gal antibodies, Transplantation, 78, 15, 10.1097/01.TP.0000130487.68051.EB · DOI
- Fang, 2012, Anti-gal antibodies in α1,3-galactosyltransferase gene knockout pigs, Xenotransplantation, 19, 305, 10.1111/j.1399-3089.2012.00710.x · DOI
- Galili, 2013, α1,3Galactosyltransferase knockout pigs produce the natural anti-Gal antibody and simulate the evolutionary appearance of this antibody in primates, Xenotransplantation, 20, 267, 10.1111/xen.12051 · DOI
- Bhende, 1952, A new blood group character related to the ABO system, Lancet, 1, 903
- Bhatia, 1974, Incidence of Bombay Oh phenotype and weaker variants of A and B antigens in Bombay (India), Vox Sang., 27, 524, 10.1111/j.1423-0410.1974.tb02450.x · doi:10.1111/j.1423-0410.1974.tb02450.x
- Gerard, 1982, H-deficient blood groups (Bombay) of Réunion Island, Am. J. Hum. Genet., 34, 937
- Mulet, 1977, Activity of 2-α-Lfucosyltransferase in human sera and red cell membranes. Study of common ABH blood donors, rare ‘Bombay’ and ‘Parabombay’ individuals, FEBS Lett., 84, 74, 10.1016/0014-5793(77)81060-0 · doi:10.1016/0014-5793(77)81060-0
- Cartron, 1983, H-deficient blood groups of Reunion Island. III. α-2-Lfucosyltransferase activity in sera of homozygous and heterozygous individuals, Am. J. Hum. Genet., 35, 497
- Balgir, 2005, Detection of a rare blood group “Bombay (Oh) Phenotype” among the Kutia Kondh primitive tribe of Orissa, India, Int. J. Hum. Genet., 5, 193, 10.1080/09723757.2005.11885925 · doi:10.1080/09723757.2005.11885925
- Gerl, 2012, Quantitative analysis of the lipidomes of the influenza virus envelope and MDCK cell apical membrane, J. Cell. Biol., 196, 213, 10.1083/jcb.201108175 · DOI · Paper page
- Campbell, 2014, Humoral response to a viral glycan correlates with survival on PROSTVAC-VF, Proc. Natl. Acad. Sci. USA, 111, E1749, 10.1073/pnas.1314722111 · DOI
- Yeh, 2010, Investigation of potential carbohydrate antigen targets for human and baboon antibodies, Xenotransplantation, 17, 197, 10.1111/j.1399-3089.2010.00579.x · DOI
- Briles, 1975, Physiological studies on the pneumococcal Forssman antigen: A choline-containing lipoteichoic acid, J. Gen. Microbiol., 86, 267, 10.1099/00221287-86-2-267 · doi:10.1099/00221287-86-2-267
- Ostrander, 1988, Isolation and characterization of the major acidic glycosphingolipids from the liver of the English sole (Parophrys vetulus). Presence of a novel ganglioside with a Forssman antigen determinant, J. Biol. Chem., 263, 3103, 10.1016/S0021-9258(18)69041-6 · doi:10.1016/s0021-9258(18)69041-6
- Bouhours, 1999, Forssman penta- and tetraglycosylceramide are xenoantigens of ostrich kidney and liver, Glycobiology, 9, 875, 10.1093/glycob/9.9.875 · doi:10.1093/glycob/9.9.875
- Kawsar, 2009, Glycan-binding profile and cell adhesion activity of American bullfrog [Rana catesbeiana] oocyte galectin-1, Protein Pept. Lett., 16, 677, 10.2174/092986609788490104 · DOI
- Larsen, 1990, Molecular cloning, sequence, and expression of a human GDP-L-fucose:β-Dgalactoside 2-α-L-fucosyltransferase cDNA that can form the H blood group antigen, Proc. Natl. Acad. Sci. USA, 87, 6674, 10.1073/pnas.87.17.6674 · doi:10.1073/pnas.87.17.6674
- Kelly, 1994, Molecular basis for H blood group deficiency in Bombay (Oh) and para-Bombay individuals, Proc. Natl. Acad. Sci. USA, 91, 5843, 10.1073/pnas.91.13.5843 · DOI · Paper page
- Kaneko, 1997, Wide variety of point mutations in the H gene of Bombay and para-Bombay individuals that inactivate H enzyme, Blood, 90, 839, 10.1182/blood.V90.2.839 · DOI
- Koda, 1997, Missense mutation of FUT1 and deletion of FUT2 are responsible for Indian Bombay phenotype of ABO blood group system, Biochem. Biophys. Res. Commun., 238, 21, 10.1006/bbrc.1997.7232 · DOI
- Wagner, 1997, Polymorphism of the h allele and the population frequency of sporadic nonfunctional alleles, Transfusion, 37, 284, 10.1046/j.1537-2995.1997.37397240210.x · DOI
- Oriol, 2000, Molecular genetics of H, Vox Sang., 78, 105
- Storry, 2006, Identification of six new alleles at the FUT1 and FUT2 loci in ethnically diverse individual s with Bombay and ParaBombay phenotypes, Transfusion, 46, 2149, 10.1111/j.1537-2995.2006.01045.x · doi:10.1111/j.1537-2995.2006.01045.x
- Dipta, 2011, The Bombay blood group: Are we out of risk?, Mymensingh Med. J., 20, 536
- Malhotra, 2014, Acute hemolytic transfusion reaction in a patient with Bombay phenotype: Implications for ABO grouping, Indian J. Hematol. Blood Transfus., 30, 108, 10.1007/s12288-013-0277-9 · doi:10.1007/s12288-013-0277-9
- Agarwal, 2016, Managing rare blood group requests—Bombay oh phenotype: Our experience with www.bombaybloodgroup.org, Blood Transfus., 14, 89
- Seymour, 2004, Evolution of the human ABO polymorphism by two complementary selective pressures, Proc. Biol. Sci., 271, 1065, 10.1098/rspb.2004.2674 · DOI
- Neil, 2005, HIV-1 incorporates ABO histo-blood group antigens that sensitize virions to complement-mediated inactivation, Blood, 105, 4693, 10.1182/blood-2004-11-4267 · DOI
- Aho, 1980, ABO associated genetic determinant in H1N1 influenza, Tissue Antigens, 16, 310, 10.1111/j.1399-0039.1980.tb00311.x · doi:10.1111/j.1399-0039.1980.tb00311.x
- Naikhin, 1989, Indicators of collective immunity to influenza depending on the blood group and sex of the population, Voprosy Virusologii, 34, 419
Cited by
Jajosky, R. P., Wu, S.-C., Zheng, L., Jajosky, A. N., Jajosky, P. G., Josephson, C. D., Hollenhorst, M. A., Sackstein, R., Cummings, R. D., Arthur, C. M., et al. (2023) · iScience · doi:10.1016/j.isci.2022.105798 · Cited by 110
The α-Gal epitope - the cause of a global allergic disease
Perusko, M., Grundström, J., Eldh, M., Hamsten, C., Apostolovic, D., & van Hage, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1335911 · Cited by 52
Chen, J. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26312 · Cited by 14
Metadata
- Authors
- Galili, U.
- Affiliations
- Department of Medicine, Rush University Medical School, Chicago, IL 60605, USA
- Venue
- Antibodies
- Publisher
- MDPI AG
- Published
- 2020-06-22
- Volume
- 9
- Issue
- 2
- Pages
- 25
- ISSN
- 2073-4468
- Cited by
- 40
- References
- 4
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.